The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
APA & MeetingsFull Access

Residents Honored for Research on Tardive Dyskinesia

Published Online:https://doi.org/10.1176/appi.pn.2018.11a29

Abstract

Photo: Stanley Caroff, M.D. (left), and Leslie Lundt, M.D. (right)

Stanley Caroff, M.D. (left), and Leslie Lundt, M.D. (right), pose with one of the winning residents of the 2018 Promising Scholars Award Program for original papers on tardive dyskinesia, Gopalkumar Rakesh, M.D., a research fellow at Duke University. The other winner was Haitham Salem, M.D., a PGY-2 psychiatry resident at the University of Texas at Houston. The residents were honored at IPS: The Mental Health Services Conference, held last month in Chicago.

Caroff is an emeritus professor of psychiatry at the University of Pennsylvania and director of the Neuroleptic Malignant Syndrome Information Service (NMSIS), and Lundt is medical director of Neurocrine Biosciences, the manufacturer of Ingrezza (valbenazine).

Both NMSIS and Neurocrine sponsored the competition. Submissions were evaluated on the basis of their relevance to tardive dyskinesia, originality, scientific rigor, clinical significance, and other factors. ■